BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 26
• 27
• 28
• 29

• Drug Development

  Provectus Pharmaceuticals Inc. Completes Patient Accrual in Phase 2 Trial of PV-10 for Metastatic Melanoma

  May 14, 2009

   · 

  1 min read
• Business

  Sinobiopharma, Inc. Announces 350% Increase in Production of Its Flagship Drug in the First Quarter of 2009 Over the Same Period in 2008

  May 14, 2009

   · 

  2 min read
• Business

  Redpoint Bio Corporation Reports First Quarter 2009 Results

  May 14, 2009

   · 

  1 min read
• Lone Star Bio

  Cyberonics Inc. Announces Conference Call to Discuss Fourth Quarter and Fiscal Year 2009 Financial Results

  May 14, 2009

   · 

  1 min read
• Business

  ULURU Inc. Announces Conference Call to Discuss Financial Results for the First Quarter Ended March 31, 2009 and to Provide a Business Update

  May 14, 2009

   · 

  1 min read
• Bio NC

  DARA BioSciences, Inc. to Present DB959 At the ‘Annual Targeting Diabetes with Novel Therapeutics’ Meeting Sponsored by Cambridge Healthtech Institute

  May 14, 2009

   · 

  1 min read
• Drug Development

  AlphaVax, Inc. Announces Full Enrollment in Phase I/II Study of Active Immunotherapy in Patients with Advanced or Metastatic Cancer

  May 14, 2009

   · 

  3 min read
• Business

  OccuLogix Inc., dba TearLab Corporation, Reports Q1-09 Financial Results

  May 14, 2009

   · 

  1 min read
• BioCapital

  ImQuest BioSciences Receives Phase I SBIR Grant to Develop a Novel Hepatitis C Virus Therapeutic Agent

  May 14, 2009

   · 

  2 min read
• ThromboGenics Ltd. Business Update

  May 14, 2009

   · 

  7 min read